Samsara BioCapital as of June 30, 2019
Portfolio Holdings for Samsara BioCapital
Samsara BioCapital holds 21 positions in its portfolio as reported in the June 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Intercept Pharmaceuticals In | 17.4 | $26M | 331k | 79.57 | |
| Odonate Therapeutics Ord | 14.9 | $23M | 616k | 36.69 | |
| Allakos | 12.5 | $19M | 447k | 42.24 | |
| Syros Pharmaceuticals | 10.1 | $15M | 1.7M | 8.82 | |
| Sutro Biopharma (STRO) | 8.5 | $13M | 1.1M | 11.38 | |
| Principia Biopharma | 8.4 | $13M | 384k | 33.19 | |
| Atreca Inc Cl A (BCEL) | 7.4 | $11M | 591k | 18.84 | |
| Gossamer Bio (GOSS) | 5.5 | $8.4M | 377k | 22.18 | |
| Liquidia Technologies (LQDA) | 3.5 | $5.3M | 659k | 8.00 | |
| Hookipa Pharma Inc equity | 2.4 | $3.6M | 530k | 6.73 | |
| Aravive | 1.8 | $2.7M | 443k | 6.00 | |
| Kalvista Pharmaceuticals (KALV) | 1.7 | $2.6M | 119k | 22.15 | |
| Catabasis Pharmaceuticals Ord | 1.6 | $2.4M | 300k | 8.07 | |
| Evelo Biosciences | 1.3 | $2.0M | 228k | 8.98 | |
| Sunesis Pharmaceuticals Inc Ne | 1.0 | $1.5M | 2.1M | 0.73 | |
| Urovant Sciences | 0.8 | $1.2M | 158k | 7.91 | |
| Regulus Therapeutics | 0.7 | $1.1M | 904k | 1.25 | |
| Millendo Therapeutics | 0.3 | $521k | 45k | 11.55 | |
| Surface Oncology | 0.1 | $221k | 78k | 2.82 | |
| Pds Biotechnology Ord (PDSB) | 0.0 | $55k | 9.2k | 6.00 | |
| Trillium Therapeutics, Inc. Cmn | 0.0 | $24k | 72k | 0.34 |
